Should I Buy BNTX? BNTX 2026 Analysis

Should You Buy Biontech SE (BNTX) Today? Analysis, Price Targets, and 2026 Outlook.

No data

Growth

Profitability

Efficiency

13 Analyst Rating

Wall Street analysts forecast BNTX stock price to rise

12 Buy

1 Hold

0 Sell

Strong Buy

Current: 93.440

Low

113

Averages

143.17

High

181

Current: 93.440

Low

113

Averages

143.17

High

181

UBS

Neutral -> Buy

upgrade

$117 -> $135

AI Analysis

2026-05-27

New

Reason

UBS

Price Target

$117 -> $135

AI Analysis

2026-05-27

New

upgrade

Neutral -> Buy

Reason

UBS upgraded BioNTech to Buy from Neutral with a price target of $135, up from $117. The firm cites its increased conviction and market opportunity for the company's oncology pipeline for the upgrade. UBS sees the PD-(L)1xVEGF bispecific class as a "transformative" modality in solid tumors and notes BioNTech has near-term clinical catalysts.

Berenberg

Buy

downgrade

$155 -> $140

2026-05-12

Reason

Berenberg

Price Target

$155 -> $140

2026-05-12

downgrade

Buy

Reason

Berenberg lowered the firm's price target on BioNTech to $140 from $155 and keeps a Buy rating on the shares. The firm says the current share price "deeply undervalues" the company's oncology pipeline. Berenberg cut the price target to reflect pressure on BioNTech's COVID-19 business, but views the company's new buyback and manufacturing footprint optimization favorably.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BNTX

Unlock Now

BNTX Should I Buy

BNTX Should I Buy

Should You Buy Biontech SE (BNTX) Today? Analysis, Price Targets, and 2026 Outlook.

No data

No data

Growth

Profitability

Efficiency

People Also Watch